11
Participants
Start Date
February 21, 2017
Primary Completion Date
December 6, 2017
Study Completion Date
January 2, 2018
Goserelin Acetate
The Pepti 10.8mg (goserelin acetate) implant is supplied as a cylindrical rod of biodegradable and biocompatible D, L Lactic and glycolic acids copolymer. Each implant contains goserelin acetate equivalent to 10.8mg of goserelin as well as a blend of high and low molecular weight range of D, L lactic and glycolic acids copolymer to total a weight of approximately 36.0mg per depot. The implant will be injected subcutaneously through the patient's anterior abdominal wall.
Exdeo Clinical Research Inc., Abbotsford
The Male / Female Health and Research Centre, Barrie
Jonathan Giddens Medicine Professional Corporation, Brampton
The Fe/Male Health Centres, Oakville
Stanley Flax Medical Professional Corporation, Toronto
Fridon Todua Research Institute of Clinical Medicine, Tbilisi
MediClubGeorgia, Tbilisi
Lead Sponsor
Peptigroupe Inc.
INDUSTRY
CMX Research
OTHER